311 related articles for article (PubMed ID: 9862719)
21. Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts.
Kawaguchi Y; Nishimagi E; Tochimoto A; Kawamoto M; Katsumata Y; Soejima M; Kanno T; Kamatani N; Hara M
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14501-6. PubMed ID: 16971486
[TBL] [Abstract][Full Text] [Related]
22. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
23. The type II interleukin-1 receptor (IL-1RII) of the bony fish gilthead seabream Sparus aurata is strongly induced after infection and tightly regulated at transcriptional and post-transcriptional levels.
López-Castejón G; Sepulcre MP; Roca FJ; Castellana B; Planas JV; Meseguer J; Mulero V
Mol Immunol; 2007 Apr; 44(10):2772-80. PubMed ID: 17234266
[TBL] [Abstract][Full Text] [Related]
24. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
[TBL] [Abstract][Full Text] [Related]
25. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts.
Penton-Rol G; Orlando S; Polentarutti N; Bernasconi S; Muzio M; Introna M; Mantovani A
J Immunol; 1999 Mar; 162(5):2931-8. PubMed ID: 10072543
[TBL] [Abstract][Full Text] [Related]
26. The membrane form of the type II IL-1 receptor accounts for inhibitory function.
Neumann D; Kollewe C; Martin MU; Boraschi D
J Immunol; 2000 Sep; 165(6):3350-7. PubMed ID: 10975853
[TBL] [Abstract][Full Text] [Related]
27. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.
Burns K; Clatworthy J; Martin L; Martinon F; Plumpton C; Maschera B; Lewis A; Ray K; Tschopp J; Volpe F
Nat Cell Biol; 2000 Jun; 2(6):346-51. PubMed ID: 10854325
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
[TBL] [Abstract][Full Text] [Related]
29. IL-1 receptor accessory protein is an essential component of the IL-1 receptor.
Cullinan EB; Kwee L; Nunes P; Shuster DJ; Ju G; McIntyre KW; Chizzonite RA; Labow MA
J Immunol; 1998 Nov; 161(10):5614-20. PubMed ID: 9820540
[TBL] [Abstract][Full Text] [Related]
30. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein.
Jensen LE; Muzio M; Mantovani A; Whitehead AS
J Immunol; 2000 May; 164(10):5277-86. PubMed ID: 10799889
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cells.
Martin M; Böl GF; Eriksson A; Resch K; Brigelius-Flohé R
Eur J Immunol; 1994 Jul; 24(7):1566-71. PubMed ID: 8026518
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone up-regulates type II IL-1 receptor in mouse primary activated astrocytes.
Pousset F; Cremona S; Dantzer R; Kelley KW; Parnet P
J Neurochem; 2001 Feb; 76(3):901-9. PubMed ID: 11158262
[TBL] [Abstract][Full Text] [Related]
34. Evidence for an intracellular activation loop in the IL-1 system.
Hofmeister R; Männel DN; Falk W
J Inflamm; 1995-1996; 47(3):151-63. PubMed ID: 9117442
[TBL] [Abstract][Full Text] [Related]
35. Human/mouse interleukin-1 receptor/receptor accessory protein interactions in IL-1beta-induced NFkappaB activation.
Layé S; Lundkvist J; Bartfai T
FEBS Lett; 1998 Jun; 429(3):307-11. PubMed ID: 9662438
[TBL] [Abstract][Full Text] [Related]
36. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells.
Pinteaux E; Parker LC; Rothwell NJ; Luheshi GN
J Neurochem; 2002 Nov; 83(4):754-63. PubMed ID: 12421347
[TBL] [Abstract][Full Text] [Related]
37. Augmentation of type I IL-1 receptor expression and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes.
Ito A; Takii T; Matsumura T; Onozaki K
J Immunol; 1999 Apr; 162(7):4260-5. PubMed ID: 10201956
[TBL] [Abstract][Full Text] [Related]
38. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
[TBL] [Abstract][Full Text] [Related]
39. Effects of IL-1 receptor accessory protein on IL-1 binding.
Wesche H; Resch K; Martin MU
FEBS Lett; 1998 Jun; 429(3):303-6. PubMed ID: 9662437
[TBL] [Abstract][Full Text] [Related]
40. IL-1 beta transduces different signals than IL-1 alpha leading to class II antigen expression on beta-insulinoma RIN-5AH cells through specific receptors.
Vassiliadis S; Soteriadou KP; Papadopoulos GK
J Recept Signal Transduct Res; 1997; 17(1-3):211-25. PubMed ID: 9029492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
